Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ATNMATNM
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ACTINIUM PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 324,945 shares of ATNM (ACTINIUM PHARMACEUTICALS INC), worth $318,553 as of 2026-Q2. The position was decreased (-3.3% shares).

Current Value

$318,553

Current Shares

324,945

Total Value Change

-$971,588

Total Shares Change

-361,208

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
324,945
-3.3%
$318,5530.0%$0.98
0
2026-Q1
Increased
336,073
+2.1%
$334,5940.0%$1.11
16
2025-Q4
Increased
328,994
+0.2%
$447,5640.0%$1.41
16
2025-Q3
Decreased
328,419
-0.4%
$525,6340.0%$1.62
0
2025-Q2
Decreased
329,689
-53.7%
$461,6970.0%$1.42
0
2025-Q1
Increased
711,801
+3.5%
$1.1M0.0%$1.81
26
2024-Q4
Increased
687,853
+0.3%
$866,8380.0%$1.17
25
2024-Q3
Increased
686,153
+3.0%
$1.3M0.0%$1.80
26

Other major holders of ATNM: BlackRock Finance, Inc., STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used